Cargando…

Impact of time-to-treatment initiation on survival in single primary non-small cell lung Cancer: A population-based study

BACKGROUND: Understanding the effects of a delayed time-to-treatment initiation(TTI) for non-small cell lung cancer (NSCLC) is vital. METHODS: We analyzed NSCLC data from the Surveillance, Epidemiology, and End Results database, focusing on lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Jun, Liu, Yan, Xia, Junyan, Luo, Yi, Zou, Heng, Wang, Hongwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559072/ https://www.ncbi.nlm.nih.gov/pubmed/37810045 http://dx.doi.org/10.1016/j.heliyon.2023.e19750

Ejemplares similares

Improvement of survival for non-small cell lung cancer over time
por: Xia, Wenjie, et al.
Publicado: (2017)

Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?
por: Liu, Yutao, et al.
Publicado: (2017)

Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study
por: Fan, Heng, et al.
Publicado: (2015)

Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient
por: Tao, Junyan, et al.
Publicado: (2020)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer
por: He, Lijie, et al.
Publicado: (2010)

Metagenes Associated with Survival in Non-Small Cell Lung Cancer
por: Urgard, Egon, et al.
Publicado: (2011)

Genetic variations in miR‐125 family and the survival of non‐small cell lung cancer in Chinese population
por: Wu, Shuangshuang, et al.
Publicado: (2019)

The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer
por: Guo, Wenjie, et al.
Publicado: (2017)

Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients’ survival
por: Lemonnier, Irawati, et al.
Publicado: (2014)

Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study
por: Taniyama, Yukari, et al.
Publicado: (2022)

Non-small Cell Lung Cancer Initially Presenting with Intracardiac Metastasis
por: Kim, Jung Han, et al.
Publicado: (2005)

Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data
por: Hopkins, Ashley M., et al.
Publicado: (2019)

Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers
por: Lou, Yanyan, et al.
Publicado: (2018)

Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning
por: Lai, Yu-Heng, et al.
Publicado: (2020)

Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non–Small Cell Lung Cancer in Taiwan
por: Chang, Wei-Ting, et al.
Publicado: (2023)

Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer
por: Wang, Fang, et al.
Publicado: (2012)

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Rusi, et al.
Publicado: (2020)

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients
por: Rothschild, S.I., et al.
Publicado: (2021)

Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients
por: Cao, Peng, et al.
Publicado: (2022)

Multiple small bowel metastasis of primary non‐small cell lung cancer
por: Kang, Do Kyun, et al.
Publicado: (2021)

Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome
por: Hong, Weiping, et al.
Publicado: (2023)

Temporal trends in non-small cell lung cancer survival in Sweden
por: Brooks, D R, et al.
Publicado: (2007)

Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma
por: Bulbul, Yilmaz, et al.
Publicado: (2010)

Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival
por: Wang, Zhaoxi, et al.
Publicado: (2015)

Editorial: Factors that impact the survival of non-small cell lung cancer
por: Hegi-Johnson, Fiona, et al.
Publicado: (2023)

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen
por: Zhao, Jun, et al.
Publicado: (2012)

The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer
por: Dai, Fuqiang, et al.
Publicado: (2010)

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
por: Ma, Junliang, et al.
Publicado: (2010)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020)

Impact of Sampling Time Variability on Tacrolimus Dosage Regimen in Pediatric Primary Nephrotic Syndrome: Single-Center, Prospective, Observational Study
por: Huang, Lingfei, et al.
Publicado: (2022)

Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow‐Up Time
por: Netterberg, Ida, et al.
Publicado: (2020)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice
por: Chen, Xin-Ru, et al.
Publicado: (2020)

Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios are associated with the efficacy of immunotherapy in stage III/IV non-small cell lung cancer
por: Lu, Xiaojuan, et al.
Publicado: (2022)

Corrigendum: Impact of sampling time variability on tacrolimus dosage regimen in pediatric primary nephrotic syndrome: Single-center, prospective, observational study
por: Huang, Lingfei, et al.
Publicado: (2022)

Lobectomy Can Improve the Survival of Patients With Non-small Cell Lung Cancer With Lung Oligometastatic
por: Wang, Lingwei, et al.
Publicado: (2021)

Midterm survival of imaging-assisted robotic lung segmentectomy for non-small-cell lung cancer
por: Chaari, Zied, et al.
Publicado: (2021)

Characteristics of nosocomial infection and its effects on the survival of chemotherapy patients with advanced non-small cell lung cancer
por: Wang, Lili, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oblbgv0o0gvhdmefus31ikkp20